Get started
Author

David Castro Corredor

Observed names: CASTRO CORREDOR, DAVID, Castro Corredor, David, Castro-Corredor, David, Corredor,David Castro, D Castro Corredor, D. Castro, D. Castro Corredor, D. Castro-Corredor, David Castro, David Castro-Corredo, David Castro-Corredor
ORCID: 0000-0001-7315-6274
Observed ORCID: 0000-0001-7315-6274
OpenAlex ID: A5006810159
Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritis
2020 · Fernanda Genre, Javier Rueda-Gotor, et al. · Scientific Reports · 84
PDF
Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis
2022 · Sara Remuzgo-Martínez, Javier Rueda-Gotor, et al. · Frontiers in Immunology · 23
Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patients
2021 · Iñigo González Mazón, Javier Rueda-Gotor, et al. · Seminars in Arthritis and Rheumatism · 20
Potential relation of cardiovascular risk factors to disease activity in patients with axial spondyloarthritis
2021 · Iván Ferraz-Amaro, Javier Rueda-Gotor, et al. · Therapeutic Advances in Musculoskeletal Disease · 20
Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis. A multicenter study on 838 patients
2022 · Javier Rueda-Gotor, Iván Ferraz-Amaro, et al. · Seminars in Arthritis and Rheumatism · 15
Real-world evidence of the antifibrotic nintedanib in rheumatoid arthritis-interstitial lung disease. National multicenter study of 74 patients
2025 · Belén Atienza-Mateo, Ana Serrano-Combarro, et al. · Seminars in Arthritis and Rheumatism · 14
Cardiovascular and disease-related features associated with extra-articular manifestations in axial spondyloarthritis. A multicenter study of 888 patients
2022 · Javier Rueda-Gotor, Iván Ferraz-Amaro, et al. · Seminars in Arthritis and Rheumatism · 11
Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological study
2021 · Javier Rueda-Gotor, Raquel López-Mejías, et al. · Arthritis Research & Therapy · 10
PDF
Baricitinib in rheumatoid arthritis-interstitial lung disease: a literature review and national multicentre study of 72 patients
2025 · Ana Serrano-Combarro, Belén Atienza-Mateo, et al. · Lara D. Veeken · 9
Cardiac amyloidosis in patients with spinal stenosis and yellow ligament hypertrophy
2023 · Martín Negreira-Caamaño, Marco Aurelio Ramírez-Huaranga, et al. · International Journal of Cardiology · 9
Sex differences in cardiovascular and disease-related features in axial spondyloarthritis. A multicenter study of 912 patients
2023 · Iván Ferraz-Amaro, Fernanda Genre, et al. · Seminars in Arthritis and Rheumatism · 8
First Spanish study on the effectiveness of ultrasound-guided sacroiliac joint injection in patients with spondyloarthritis
2022 · Marco A Ramírez Huaranga, David Castro Corredor, et al. · Rheumatology Advances in Practice · 7
PDF
Imbalanced machine learning classification models for removal biosimilar drugs and increased activity in patients with rheumatic diseases
2023 · David Castro Corredor, Luis Ángel Calvo Pascual · PLoS ONE · 6
PDF
After Failure With Acenocoumarol, Rivaroxaban in Antiphospholipid Syndrome: A Report of 2 Cases
2018 · Javier José Mateos Rodríguez, David Bellido, et al. · Reumatología Clínica (English Edition) · 6
Real-World Experience With Janus Kinase Inhibitors in Immune-Mediated Diseases: Clinical Experience of a University Hospital
2024 · Marco Aurelio Ramirez Huaranga, Luis Angel Calvo Pascual, et al. · Cureus · 5
PDF
La sinoviortesis radioisotópica en el control de la sinovitis refractaria en Castilla La-Mancha. Una experiencia de 10 años
2019 · David Castro Corredor, Wilson Rafael Martínez Bravo, et al. · Reumatología Clínica · 5
Nefritis túbulo-intersticial aguda en paciente con espondiloartritis axial HLA-B27 en tratamiento con adalimumab
2017 · David Castro Corredor, María Dolores Sánchez de la Nieta, et al. · Reumatología Clínica · 5
Sex-specific impact of inflammation on traditional cardiovascular risk factors and atherosclerosis in axial spondyloarthritis. A multicentre study of 913 patients
2024 · Ivan Ferraz-Amaro, Fernanda Genre, et al. · RMD Open · 4
Rivaroxabán en síndrome antifosfolipídico tras fracaso con acenocumarol: a propósito de 2 casos
2017 · Javier José Mateos Rodríguez, David Bellido, et al. · Reumatología Clínica · 4
Predictors of clinically meaningful bone mineral density gains with romosozumab: An explainable machine leaning analysis of a real-world cohort
2025 · David Castro Corredor, Luis Ángel Calvo Pascual · Bone Reports · 3
Impact of Social Factors on Visual Analog Scale Pain in Patients With Spondyloarthritis: A Propensity Score Matching Analysis
2025 · Luis Ángel Calvo Pascual, David Castro Corredor, et al. · Arthritis Care & Research · 3
Inflammatory activity levels on patients with anti-TNF therapy: most important factors and a decision tree model based on REGISPONSER and RESPONDIA registries
2025 · David Castro Corredor, Luis Ángel Calvo Pascual, et al. · Therapeutic Advances in Musculoskeletal Disease · 3
Pos0835 Effectiveness and Safety of Jak Inhibitors in Rheumatoid Arthritis-interstitial Lung Disease. National Multicenter Study of 57 Patients
2023 · A. Serrano-Combarro, B. Atienza-Mateo, et al. · Annals of the Rheumatic Diseases · 3
PDF
Ab1122 Have Treatments for Autoimmune Diseases Worsened the Prognosis of Covid-19 Infection?
2022 · A.I. Rebollo Giménez, M. González Peñas, et al. · Annals of the Rheumatic Diseases · 3
PDF
Vitamin D, an inflammatory activity marker for spondyloarthritis?
2020 · David Castro Corredor, Marco Aurelio Ramírez Huaranga, et al. · Archives of Osteoporosis · 3
Works count: 100
Citation count: 316
H-index: 9
I10-index: 8
Year
Topic
Type